JRCT ID: jRCTs021250040
Registered date:26/12/2025
Glucose metabolism assessment method with oral glucose tolerance test with breath test
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Healthy person |
| Date of first enrollment | 26/12/2025 |
| Target sample size | 20 |
| Countries of recruitment | |
| Study type | Other |
| Intervention(s) | An oral glucose load of 75.5 g is administered early in the morning on an empty stomach: 150 mL of a 50% glucose solution containing 75 g glucose (Otsuka Pharmaceutical) and 0.5 g 13C-labeled glucose (Otsuka Pharmaceutical - Cambridge Isotope Laboratories) dissolved in 75 mL of purified water ( Otsuka Pharmaceutical) dissolved in 75 mL purified water (Otsuka Pharmaceutical) is ingested orally. At 15, 30, 45, 60, 90, 120, 150, and 180 minutes, subjects exhale approximately 200 mL of breath into a breath collection bag (breath sample collection), and blood is drawn (5 mL of blood at 0 minutes, 2 mL of blood from 14 to 180 minutes) from the elbow vein. Subjects will collect blood samples using an indwelling needle to reduce the number of punctures for a total of 9 blood draws. |
Outcome(s)
| Primary Outcome | 13CO2 exhalation in exhaled breath |
|---|---|
| Secondary Outcome | Association of 13CO2 expiratory excretion in breath with insulin secretory capacity (HOMA beta), insulin resistance (HOMA-IR), and hepatic insulin clearance (C-peptide/insulin ratio) |
Key inclusion & exclusion criteria
| Age minimum | >= 18age old |
|---|---|
| Age maximum | < 65age old |
| Gender | Male |
| Include criteria | Healthy male adult Between 20 and 65 years of age at the time consent is obtained Those understand the explanation of study participation and sign a written consent form |
| Exclude criteria | Those having diseases that affect glucose metabolism (diabetes, thyroid disease, liver dysfunction, renal dysfunction, under steroid treatment, cancer, etc.) Those suggestive of hypotonic dehydration (physical condition on the day of examination will be interviewed to determine whether there is fatigue, dry mouth, decreased urine output, or loss of electrolytes due to fever, diarrhea, vomiting, etc.) Body mass index (BMI) of 30 or higher At least 110 mg/dL measured with a simple blood glucose meter before this test Taking any medication Those who the investigator deems inappropriate for the subject of this study |
Related Information
| Primary Sponsor | Sawada Shojiro |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Shojiro Sawada |
| Address | Fukumuro 1-12-1, Miyaginoku, Sendai, Miyagi Miyagi Japan 983-8512 |
| Telephone | +81-22-259-1221 |
| ssawada@tohoku-mpu.ac.jp | |
| Affiliation | Tohoku Medical and Pharmaceutical University Hospital |
| Scientific contact | |
| Name | Shojiro Sawada |
| Address | Fukumuro 1-12-1, Miyaginoku, Sendai, Miyagi Miyagi Japan 983-8512 |
| Telephone | +81-22-259-1221 |
| ssawada@tohoku-mpu.ac.jp | |
| Affiliation | Tohoku Medical and Pharmaceutical University Hospital |